Cold & Cough Remedies - Eastern Africa

In Eastern Africa, the revenue in the Cold & Cough Remedies market market in 2024 amounts to US$241.30m.
It is projected that the market will experience an annual growth rate of 9.35% (CAGR 2024-2029).
Comparatively, the United States generates the highest revenue in this market, with US$11.19bn in 2024.
When considering the total population, per person revenues of US$0.53 are generated in 2024.
Despite a growing demand for Cold & Cough Remedies in Eastern Africa, traditional herbal remedies still dominate the market.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Eastern Africa is experiencing significant growth due to several factors. Customer preferences for over-the-counter remedies, increasing urbanization, and rising healthcare awareness are all contributing to the expansion of the market in this region.Customer preferences in Eastern Africa are shifting towards over-the-counter remedies for cold and cough symptoms. This is driven by the convenience and accessibility of these products, as well as the desire for immediate relief. Consumers are increasingly seeking self-care options and are willing to try different remedies to alleviate their symptoms. As a result, the demand for cold and cough remedies in Eastern Africa is on the rise.In addition, the increasing urbanization in the region is playing a role in the growth of the market. Urban areas are experiencing rapid population growth, leading to higher levels of pollution and exposure to respiratory infections. As a result, there is a greater need for cold and cough remedies to address these health issues. Urban dwellers are also more likely to have access to pharmacies and healthcare facilities, making it easier for them to purchase these remedies.Furthermore, rising healthcare awareness is driving the demand for cold and cough remedies in Eastern Africa. People are becoming more conscious of their health and are seeking ways to prevent and treat common illnesses. This includes taking proactive measures to manage cold and cough symptoms. As a result, there is a growing demand for remedies that can provide relief and help individuals recover quickly.Local special circumstances in Eastern Africa also contribute to the development of the Cold & Cough Remedies market. The region experiences a high burden of respiratory diseases, including pneumonia and tuberculosis. These conditions often lead to cold and cough symptoms, creating a need for effective remedies. Additionally, the prevalence of traditional medicine practices in some countries in Eastern Africa provides an opportunity for the market to offer a blend of traditional and modern remedies.Underlying macroeconomic factors, such as population growth, increasing disposable incomes, and improving healthcare infrastructure, are further driving the growth of the Cold & Cough Remedies market in Eastern Africa. As the population continues to expand, the demand for healthcare products and services, including cold and cough remedies, is expected to increase. Rising disposable incomes enable individuals to afford these remedies, while improving healthcare infrastructure ensures better access to healthcare facilities and products.In conclusion, the Cold & Cough Remedies market in Eastern Africa is developing due to customer preferences for over-the-counter remedies, increasing urbanization, rising healthcare awareness, local special circumstances, and underlying macroeconomic factors. As these factors continue to shape the market, there is a growing opportunity for companies to meet the demand for cold and cough remedies in this region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.